Bacteria fighting back: How pathogens target and subvert the host innate immune system

Molecular Cell

Volumn 54, Issue 2, 2014, Pages 321-328

  Reddick, L Evan ^a   Alto, Neal M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PATTERN RECOGNITION RECEPTOR; POLYPEPTIDE ANTIBIOTIC AGENT;

ANTIMICROBIAL ACTIVITY; BACTERIAL IMMUNITY; BACTERIAL VIRULENCE; CELL MIGRATION; CYTOKINE PRODUCTION; ENZYME ACTIVITY; HOST; IMMUNE EVASION; INNATE IMMUNITY; MICROBIAL DIVERSITY; NONHUMAN; PATHOGENESIS; PHOSPHORYLATION AND DEPHOSPHORYLATION; PROTEIN SECRETION; REVIEW; SECRETORY PATHWAY; SELF DEFENSE; SIGNAL TRANSDUCTION; TARGET ORGANISM;

BACTERIA; HOST-PATHOGEN INTERACTIONS; IMMUNE EVASION; IMMUNITY, INNATE; MODELS, IMMUNOLOGICAL; RECEPTORS, PATTERN RECOGNITION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84899134307     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2014.03.010     Document Type: Review

References (57)

1. Ashida H., Kim M., Schmidt-Supprian M., Ma A., Ogawa M., Sasakawa C. A bacterial E3 ubiquitin ligase IpaH9.8 targets NEMO/IKKgamma to dampen the host NF-kappaB-mediated inflammatory response. Nat. Cell Biol. 2010, 12:66-73. 1-9.
2. Brodsky I.E., Palm N.W., Sadanand S., Ryndak M.B., Sutterwala F.S., Flavell R.A., Bliska J.B., Medzhitov R. A Yersinia effector protein promotes virulence by preventing inflammasome recognition of the type III secretion system. Cell Host Microbe 2010, 7:376-387.
3. Burnaevskiy N., Fox T.G., Plymire D.A., Ertelt J.M., Weigele B.A., Selyunin A.S., Way S.S., Patrie S.M., Alto N.M. Proteolytic elimination of N-myristoyl modifications by the Shigella virulence factor IpaJ. Nature 2013, 496:106-109.
4. Creagh E.M., O'Neill L.A. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol. 2006, 27:352-357.
5. Dev A., Iyer S., Razani B., Cheng G. NF-κB and innate immunity. Curr. Top. Microbiol. Immunol. 2011, 349:115-143.
6. Dong N., Zhu Y., Lu Q., Hu L., Zheng Y., Shao F. Structurally distinct bacterial TBC-like GAPs link Arf GTPase to Rab1 inactivation to counteract host defenses. Cell 2012, 150:1029-1041.
7. Duesbery N.S., Webb C.P., Leppla S.H., Gordon V.M., Klimpel K.R., Copeland T.D., Ahn N.G., Oskarsson M.K., Fukasawa K., Paull K.D., Vande Woude G.F. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science 1998, 280:734-737.
8. Ernst C.M., Staubitz P., Mishra N.N., Yang S.J., Hornig G., Kalbacher H., Bayer A.S., Kraus D., Peschel A. The bacterial defensin resistance protein MprF consists of separable domains for lipid lysinylation and antimicrobial peptide repulsion. PLoS Pathog. 2009, 5:e1000660.
9. Fritz J.H., Ferrero R.L., Philpott D.J., Girardin S.E. Nod-like proteins in immunity, inflammation and disease. Nat. Immunol. 2006, 7:1250-1257.
10. Gao X., Wang X., Pham T.H., Feuerbacher L.A., Lubos M.L., Huang M., Olsen R., Mushegian A., Slawson C., Hardwidge P.R. NleB, a bacterial effector with glycosyltransferase activity, targets GAPDH function to inhibit NF-κB activation. Cell Host Microbe 2013, 13:87-99.
11. Hayden M.S., Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008, 132:344-362.
12. Hurtado-Guerrero R., Dorfmueller H.C., van Aalten D.M. Molecular mechanisms of O-GlcNAcylation. Curr. Opin. Struct. Biol. 2008, 18:551-557.
13. Janeway C.A. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 1989, 54:1-13.
14. Jones R.M., Wu H., Wentworth C., Luo L., Collier-Hyams L., Neish A.S. Salmonella AvrA Coordinates Suppression of Host Immune and Apoptotic Defenses via JNK Pathway Blockade. Cell Host Microbe 2008, 3:233-244.
15. Kenny B., DeVinney R., Stein M., Reinscheid D.J., Frey E.A., Finlay B.B. Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 1997, 91:511-520.
16. Kim D.W., Lenzen G., Page A.L., Legrain P., Sansonetti P.J., Parsot C. The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes. Proc. Natl. Acad. Sci. USA 2005, 102:14046-14051.
17. Kim J., Thanabalasuriar A., Chaworth-Musters T., Fromme J.C., Frey E.A., Lario P.I., Metalnikov P., Rizg K., Thomas N.A., Lee S.F., et al. The bacterial virulence factor NleA inhibits cellular protein secretion by disrupting mammalian COPII function. Cell Host Microbe 2007, 2:160-171.
18. Kovalenko A., Wallach D. If the prophet does not come to the mountain: dynamics of signaling complexes in NF-kappaB activation. Mol. Cell 2006, 22:433-436.
19. Lauth X., von Köckritz-Blickwede M., McNamara C.W., Myskowski S., Zinkernagel A.S., Beall B., Ghosh P., Gallo R.L., Nizet V. M1 protein allows Group A streptococcal survival in phagocyte extracellular traps through cathelicidin inhibition. J.Innate Immun. 2009, 1:202-214.
20. Li H., Xu H., Zhou Y., Zhang J., Long C., Li S., Chen S., Zhou J.M., Shao F. The phosphothreonine lyase activity of a bacterial type III effector family. Science 2007, 315:1000-1003.
21. Li S., Zhang L., Yao Q., Li L., Dong N., Rong J., Gao W., Ding X., Sun L., Chen X., et al. Pathogen blocks host death receptor signalling by arginine GlcNAcylation of death domains. Nature 2013, 501:242-246.
22. Matsuura M. Structural Modifications of Bacterial Lipopolysaccharide that Facilitate Gram-Negative Bacteria Evasion of Host Innate Immunity. Front Immunol 2013, 4:109.
23. McGillivray S.M., Ebrahimi C.M., Fisher N., Sabet M., Zhang D.X., Chen Y., Haste N.M., Aroian R.V., Gallo R.L., Guiney D.G., et al. ClpX contributes to innate defense peptide resistance and virulence phenotypes of Bacillus anthracis. J.Innate Immun. 2009, 1:494-506.
24. Medzhitov R., Preston-Hurlburt P., Janeway C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388:394-397.
25. Miao E.A., Mao D.P., Yudkovsky N., Bonneau R., Lorang C.G., Warren S.E., Leaf I.A., Aderem A. Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc. Natl. Acad. Sci. USA 2010, 107:3076-3080.
26. Montminy S.W., Khan N., McGrath S., Walkowicz M.J., Sharp F., Conlon J.E., Fukase K., Kusumoto S., Sweet C., Miyake K., et al. Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response. Nat. Immunol. 2006, 7:1066-1073.
27. Mounier J., Boncompain G., Senerovic L., Lagache T., Chrétien F., Perez F., Kolbe M., Olivo-Marin J.C., Sansonetti P.J., Sauvonnet N. Shigella effector IpaB-induced cholesterol relocation disrupts the Golgi complex and recycling network to inhibit host cell secretion. Cell Host Microbe 2012, 12:381-389.
28. Mukherjee S., Keitany G., Li Y., Wang Y., Ball H.L., Goldsmith E.J., Orth K. Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science 2006, 312:1211-1214.
29. Mukherjee S., Negi V.S., Keitany G., Tanaka Y., Orth K. Invitro activation of the IkappaB kinase complex by human T-cell leukemia virus type-1 Tax. J.Biol. Chem. 2008, 283:15127-15133.
30. Nandan D., Lo R., Reiner N.E. Activation of phosphotyrosine phosphatase activity attenuates mitogen-activated protein kinase signaling and inhibits c-FOS and nitric oxide synthase expression in macrophages infected with Leishmania donovani. Infect. Immun. 1999, 67:4055-4063.
31. Newton H.J., Pearson J.S., Badea L., Kelly M., Lucas M., Holloway G., Wagstaff K.M., Dunstone M.A., Sloan J., Whisstock J.C., et al. The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65. PLoS Pathog. 2010, 6:e1000898.
32. Olsen R.L., Echtenkamp F., Cheranova D., Deng W., Finlay B.B., Hardwidge P.R. The enterohemorrhagic Escherichia coli effector protein NleF binds mammalian Tmp21. Vet. Microbiol. 2013, 164:164-170.
33. Orth K., Palmer L.E., Bao Z.Q., Stewart S., Rudolph A.E., Bliska J.B., Dixon J.E. Inhibition of the mitogen-activated protein kinase kinase superfamily by a Yersinia effector. Science 1999, 285:1920-1923.
34. Paciello I., Silipo A., Lembo-Fazio L., Curcurù L., Zumsteg A., Noël G., Ciancarella V., Sturiale L., Molinaro A., Bernardini M.L. Intracellular Shigella remodels its LPS to dampen the innate immune recognition and evade inflammasome activation. Proc. Natl. Acad. Sci. USA 2013, 110:E4345-E4354.
35. Paquette N., Conlon J., Sweet C., Rus F., Wilson L., Pereira A., Rosadini C.V., Goutagny N., Weber A.N., Lane W.S., et al. Serine/threonine acetylation of TGFβ-activated kinase (TAK1) by Yersinia pestis YopJ inhibits innate immune signaling. Proc. Natl. Acad. Sci. USA 2012, 109:12710-12715.
36. Pearson J.S., Giogha C., Ong S.Y., Kennedy C.L., Kelly M., Robinson K.S., Lung T.W., Mansell A., Riedmaier P., Oates C.V., et al. A type III effector antagonizes death receptor signalling during bacterial gut infection. Nature 2013, 501:247-251.
37. Poltorak A., He X., Smirnova I., Liu M.Y., Van Huffel C., Du X., Birdwell D., Alejos E., Silva M., Galanos C., et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998, 282:2085-2088.
38. Poltorak A., Smirnova I., He X., Liu M.Y., Van Huffel C., McNally O., Birdwell D., Alejos E., Silva M., Du X., et al. Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region. Blood Cells Mol. Dis. 1998, 24:340-355.
39. Pruneda J.N., Smith F.D., Daurie A., Swaney D.L., Villén J., Scott J.D., Stadnyk A.W., Le Trong I., Stenkamp R.E., Klevit R.E., et al. E2~Ub conjugates regulate the kinase activity of Shigella effector OspG during pathogenesis. EMBO J. 2014, 33:437-449.
40. Rebeil R., Ernst R.K., Gowen B.B., Miller S.I., Hinnebusch B.J. Variation in lipid A structure in the pathogenic yersiniae. Mol. Microbiol. 2004, 52:1363-1373.
41. Rohde J.R., Breitkreutz A., Chenal A., Sansonetti P.J., Parsot C. Type III secretion effectors of the IpaH family are E3 ubiquitin ligases. Cell Host Microbe 2007, 1:77-83.
42. Sanada T., Kim M., Mimuro H., Suzuki M., Ogawa M., Oyama A., Ashida H., Kobayashi T., Koyama T., Nagai S., et al. The Shigella flexneri effector OspI deamidates UBC13 to dampen the inflammatory response. Nature 2012, 483:623-626.
43. Selyunin A.S., Sutton S.E., Weigele B.A., Reddick L.E., Orchard R.C., Bresson S.M., Tomchick D.R., Alto N.M. The assembly of a GTPase-kinase signalling complex by a bacterial catalytic scaffold. Nature 2011, 469:107-111.
44. Selyunin A.S., Reddick L.E., Weigele B.A., Alto N.M. Selective protection of an ARF1-GTP signaling axis by a bacterial scaffold induces bidirectional trafficking arrest. Cell Rep 2014, 6:878-891.
45. Takaoka A., Shinohara S. DNA sensors in innate immune system. Uirusu 2008, 58:37-46.
46. Thanabalasuriar A., Bergeron J., Gillingham A., Mimee M., Thomassin J.L., Strynadka N., Kim J., Gruenheid S. Sec24 interaction is essential for localization and virulence-associated function of the bacterial effector protein NleA. Cell. Microbiol. 2012, 14:1206-1218.
47. Uematsu S., Akira S. Toll-like receptors and Type I interferons. J.Biol. Chem. 2007, 282:15319-15323.
48. van Vliet S.J., den Dunnen J., Gringhuis S.I., Geijtenbeek T.B., van Kooyk Y. Innate signaling and regulation of Dendritic cell immunity. Curr. Opin. Immunol. 2007, 19:435-440.
49. Wei P., Wong W.W., Park J.S., Corcoran E.E., Peisajovich S.G., Onuffer J.J., Weiss A., Lim W.A. Bacterial virulence proteins as tools to rewire kinase pathways in yeast and immune cells. Nature 2012, 488:384-388.
50. Wu H., Jones R.M., Neish A.S. The Salmonella effector AvrA mediates bacterial intracellular survival during infection invivo. Cell. Microbiol. 2012, 14:28-39.
51. Yan D., Wang X., Luo L., Cao X., Ge B. Inhibition of TLR signaling by a bacterial protein containing immunoreceptor tyrosine-based inhibitory motifs. Nat. Immunol. 2012, 13:1063-1071.
52. Yen H., Ooka T., Iguchi A., Hayashi T., Sugimoto N., Tobe T. NleC, a type III secretion protease, compromises NF-κB activation by targeting p65/RelA. PLoS Pathog. 2010, 6:e1001231.
53. Zhang Z., Jimi E., Bothwell A.L. Receptor activator of NF-kappa B ligand stimulates recruitment of SHP-1 to the complex containing TNFR-associated factor 6 that regulates osteoclastogenesis. J.Immunol. 2003, 171:3620-3626.
54. Zhang L., Ding X., Cui J., Xu H., Chen J., Gong Y.N., Hu L., Zhou Y., Ge J., Lu Q., et al. Cysteine methylation disrupts ubiquitin-chain sensing in NF-κB activation. Nature 2012, 481:204-208.
55. Zhao Y., Yang J., Shi J., Gong Y.N., Lu Q., Xu H., Liu L., Shao F. The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature 2011, 477:596-600.
56. Zhou Y., Dong N., Hu L., Shao F. The Shigella type three secretion system effector OspG directly and specifically binds to host ubiquitin for activation. PLoS ONE 2013, 8:e57558.
57. Zhu Y., Li H., Long C., Hu L., Xu H., Liu L., Chen S., Wang D.C., Shao F. Structural insights into the enzymatic mechanism of the pathogenic MAPK phosphothreonine lyase. Mol. Cell 2007, 28:899-913.